10 Oversold Insurance Stocks to Buy According to Analysts

Industry Overview - The US insurance market, valued at $3.35 trillion, is transitioning from "hard market" volatility to a phase of tactical stability, with premium growth expected to slow to about 4% in 2026 from 5.5% in 2025 [2] - Return on equity (ROE) is projected to remain stable at 10%, supported by rising investment rates estimated at 4.2% [2] - The property and casualty (P&C) sector is experiencing a bifurcated landscape, with commercial property rates decreasing by high single digits to over 20% for well-protected risks, while the casualty sector faces pressures from "social inflation" and increasing jury awards [3] Technology Trends - The insurance industry is expected to shift from AI experimentation to widespread operational implementation by 2026, with technology investments projected to exceed $173 billion, reflecting a growth of approximately 7.8% [4] - Leading insurers are integrating advanced AI capabilities into their operations, which is anticipated to increase expense ratios by about two percentage points [4] Company Highlights Aegon Ltd. (NYSE:AEG) - Aegon Ltd. has seen its price target increased by Citi to EUR 8.02 from EUR 7.69, maintaining a Buy rating [9] - The company has expanded its presence in China by establishing Aegon Insurance Asset Management Company, which began operations on February 2, 2026, after obtaining its insurance asset management license [10][11] - Aegon's net result for 2H 2025 was €375 million, down from €741 million in 2H 2024, while the full-year net result rose 45% to €980 million, supported by favorable market conditions [12] eHealth, Inc. (NASDAQ:EHTH) - eHealth, Inc. has been identified as an oversold stock, with RBC Capital reducing its price target to $3 from $9 while maintaining a Sector Perform rating [14] - The company reported a 4% year-over-year increase in quarterly sales to $326.2 million for Q4 2025, with total revenue for the fiscal year reaching $554 million, also a 4% increase [15] - Despite strong sales growth, GAAP net income for Q4 fell to $87.2 million from $97.5 million a year earlier due to a higher effective tax rate, while adjusted EBITDA increased by 10% to $132.9 million [16]